MDL Motion Filed for DuPont C-8 Water Contamination Lawsuits

DuPont has filed a request to consolidate nearly 30 environmental tort lawsuits filed in the federal court system by Ohio and West Virginia residents who allege that the company contaminated their drinking water with a chemical known as C-8. 

The lawsuits include both personal injury claims and wrongful death lawsuits from four water districts in Ohio and two in West Virginia.

On January 11, DuPont filed a motion (PDF) with the U.S. Judicial Panel on Multidistrict Litigation (JPML), seeking to transfer all of the claims to either the Southern District of Ohio or the Southern District of West Virginia, for coordinated pretrial proceedings as part of a C-8 water contamination MDL, or multidistrict litigation.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

The complaints are linked to alleged releases of perfluorooctanoic acid (PFOA), also known as C-8 or C8, from DuPont’s Washington Works Plant in Parkersburg, West Virginia prior to 2004. The chemical is used to manufacture products like Teflon and Gore-Tex.

C-8 is a toxic cancer-causing agent, and stays in the environment indefinitely; never breaking down, according to allegations in the complaints. Studies have linked C-8 exposure to kidney disease, thyroid disease, ulcerative colitis, testicular cancer, pregnancy-induced hypertension, and increases in cholesterol.

In the wake of a 2005 class action lawsuit brought by residents against Du Pont, a panel of independent epidemiologists was assigned to look at the dangers of C-8. In a study released in July, they confirmed many of the ailments linked to exposure. The study looked at 70,000 residents who were exposed to the chemical via their drinking water.

DuPont noted in its MDL motion that all of the lawsuits involve plaintiffs who suffer from one of the C-8 side effects confirmed by the science panel. DuPont notes that since the class action involved some 80,000 participants, who can sue the company individually based on the science panel’s findings under the terms of the original class action lawsuit, the company expects many more complaints to be filed.

Establishing an MDL for the DuPont C-8 water contamination lawsuits would reduce duplicative discovery, avoid inconsistent rulings from different judges and serve the convenience of the witnesses, the parties and the courts, according to the request filed by DuPont.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs
AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs (Posted today)

Lawsuit blames PFAS manufacturers for failing to prevent water contamination by their chemicals, or warn municipalities and the public about the potential risks of ulcerative colitis and other diseases as a result of exposure.

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted yesterday)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted yesterday)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.